Aarti Industries Q1 Review - In-Line Quarter; Growth Guidance Intact: Systematix
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Research Report
Aarti Industries Ltd.'s Q1 FY22 result was broadly in line with our estimate with net sales/Ebitda/adjusted profit after tax growth of 40%/72%/101% YoY and 9%/21%/21% QoQ largely led by higher commodity prices.
Key chemistries volume growth was 20% YoY/down 15% QoQ to 26,225 tonne. Exports/domestic growth was 16%/9% QoQ.
Gross margin was flat at 53.7% QoQ as spreads were a mixed bag - chlorination and toluene chains saw a decline in spreads while nitro chloro benzenes and phlyenediamines chains witnessed spread improvement.
Operating profit margin improved to 23.8% versus 19.4% YoY and 21.5% QoQ led by lower staff costs and other expenses.
Aarti Industries' management remains confident of achieving its sales growth guidance of 30-35% during FY21-24 and margin improvement from FY23.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.